Table:
begin	end	state
1	25	cytoplasmic
26	46	transmembrane
47	65	non-cytoplasmic
66	87	transmembrane
88	98	cytoplasmic
99	119	transmembrane
120	127	non-cytoplasmic
128	152	transmembrane
153	162	cytoplasmic
163	186	transmembrane
187	196	non-cytoplasmic
197	216	transmembrane
217	250	cytoplasmic
251	273	transmembrane
274	288	non-cytoplasmic
289	310	transmembrane
311	316	cytoplasmic
317	334	transmembrane
335	345	non-cytoplasmic
346	369	transmembrane
370	379	cytoplasmic
380	402	transmembrane
403	407	non-cytoplasmic
408	429	transmembrane
430	437	cytoplasmic

Input:
>N515DRAFT_1367 FitnessBrowser__Dyella79:N515DRAFT_1367
MTQAAPSVSPLDSSAPRLNRNDLRTLALAALGGALEFYDFVVFVFFTKALGQLFFPADMP
EWLAQVQVYGIFAAGYLARPLGGIVMAHFGDRTGRKRMFTLSVFLMALPTLCIGLLPTYA
QLGVFAPMLLLLLRVVQGVAIGGEVPGAWVFVAEHAPPGRVGFACASLTSGLTAGILIGS
LVAAGVTGMGAEKMLAYGWRLPFILGGVFGFFAVWLRRWLSETPVFAELRERKELASELP
LKRVMTGHLGGVLLSMLVTWMLTAAVVVVILMTPTLVQSSFHLPQKLAFHGNSLAALMLC
FGCIAGGVAVDRFGRGWSLLVGSVALLVTTYLLYRDLGQGAEHFMLLYALAGLCVGVVGV
VPAVMVAAFPPAVRFSGLSFSYNIAYAVFGAITPPLIAYLAAKLGPMAPAHYVAVTAAIG
VLCAVYLLTTRREFHER

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server